Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential dose-finding study of nalbuphine with propofol for outpatient hysteroscopy anesthesia
ChiCTR2100042494Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Jan 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nalbuphine and propofol in None, sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: Dosage of nalbuphine, Dosage of propofol and 4 more. Started Jan 2021; status: recruiting.
02
Drugs
nalbuphinepropofol
Beyond the preview
Go deeper on ChiCTR2100042494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042494.